The Capitol LedgerEvery move in Congress, on the record
HomeBillsRecordsLedger AI

The Capitol Ledger

Built from the Congressional Record and Congress.gov. Every summary links to its source.

AboutFAQFeedbackTerms of ServicePrivacy Policy
Follow us onlineInstagram

Summaries are AI-generated from primary sources. Verify anything important against the original record.

The Capitol Ledger

Built from the Congressional Record and Congress.gov. Every summary links to its source.

The projectAboutFAQFeedback
LegalTerms of ServicePrivacy Policy
Follow us onlineInstagram

Summaries are AI-generated from primary sources. Verify anything important against the original record.

All bills
S. 4446·119th Congress·Introduced Apr 30, 2026

PRESS Act

IntroducedCrime and Law EnforcementSubstantive
View bill text
Sponsor
Sen. Moody, Ashley [R-FL]
Committees
Judiciary Committee (primary)
Last action
Apr 30, 2026

Bottom line

This bill expands federal law enforcement's ability to prosecute individuals involved in the production and distribution of illicit drug manufacturing equipment intended for unlawful importation into the United States, increasing potential prison sentences.

What it actually does

This bill amends the Controlled Substances Import and Export Act to make it unlawful to manufacture or distribute pill press machines, encapsulating machines, and related equipment or materials if one intends or knows they will be used to produce controlled substances or listed chemicals that will be unlawfully imported into the United States. It also establishes new, enhanced criminal penalties for these violations, including provisions for extraterritorial jurisdiction.

Proponents argue

Supporters argue this bill is a critical step in combating the influx of illicit synthetic drugs, particularly fentanyl, by targeting the upstream supply chain of manufacturing equipment. They contend that current laws are insufficient to address the global nature of drug trafficking and that expanding extraterritorial jurisdiction and increasing penalties will deter those who facilitate drug production abroad, ultimately saving lives in the U.S.

Opponents contend

Critics might argue that while the intent is laudable, expanding extraterritorial jurisdiction could lead to complex international legal challenges and potentially strain diplomatic relations. They might also raise concerns about the broad language 'any equipment, chemical, product, or material' potentially ensnaring legitimate businesses or individuals, or that focusing solely on equipment might not address the root causes of drug demand or the adaptability of illicit manufacturers.

The bill is concise and can be read and understood within a short timeframe, allowing for adequate evaluation.

Section 2(a), amending Section 1009 of the Controlled Substances Import and Export Act (21 U.S.C. 959)

Prohibiting Manufacture/Distribution of Illicit Drug Manufacturing Equipment for Unlawful Importation

prominently featuredmoderately complex

This provision makes it illegal for any person to manufacture or distribute equipment such as pill presses, encapsulating machines, press punches, die systems, gelatin capsules, or any related equipment, chemicals, products, or materials. This prohibition applies if the person intends or knows that the equipment will be used to manufacture a controlled substance or listed chemical, and also intends, knows, or has reasonable cause to believe that the resulting substance or chemical will be unlawfully imported into the United States. This expands U.S. jurisdiction to cover such activities even if they occur outside U.S. borders.

GroupImpactMechanismScale
GroupIndividuals and entities involved in manufacturing or distributing pill press machines and related equipment/materialsImpactIncreased legal risk and potential criminal liability for actions taken both within and outside the U.S.MechanismExpansion of prohibited acts under the Controlled Substances Import and Export Act to include extraterritorial activities related to drug manufacturing equipment.ScaleGlobal, targeting the international supply chain of illicit drug manufacturing.

Supporters argue

Supporters argue this provision is essential to disrupt the supply chain of illicit drugs at their source by targeting the tools used to produce them, especially synthetic opioids like fentanyl. They believe it closes a loophole by allowing prosecution of those who facilitate drug production abroad.

Critics contend

Critics might express concern that the broad language 'any equipment, chemical, product, or material' could inadvertently impact legitimate industries or individuals, or that enforcing extraterritorial jurisdiction could be challenging and lead to international disputes.

Tradeoffs

This provision balances the desire to combat international drug trafficking by expanding legal reach against potential challenges of enforcement, international legal cooperation, and the risk of overreach affecting legitimate commerce.

Section 2(b), amending Section 1010 of the Controlled Substances Import and Export Act (21 U.S.C. 960)

Enhanced Penalties for Illicit Drug Manufacturing Equipment Offenses

prominently featuredstraightforward

This section establishes new criminal penalties for violating the prohibitions on manufacturing or distributing illicit drug manufacturing equipment. It sets a maximum sentence of 8 years for general violations of the new subsection (c) of section 1009. For violations involving a List I chemical, the maximum sentence is 20 years. Additionally, violations involving more than 1,000 kilograms of a chemical or product or more than 100 tableting or encapsulating machines carry a maximum sentence of 15 years.

FOUND

Directs the United States Sentencing Commission to review and amend the Federal sentencing guidelines and policy statements as appropriate, in accordance with this Act and its amendments.

Section 2(c)

Why it matters:This is standard legislative practice to ensure that new criminal statutes are properly integrated into the existing sentencing framework, providing clarity and consistency for judicial application. It is not necessarily intended to be evasive.

Case for: Ensures that the intent of Congress regarding sentencing for these new offenses is properly reflected in judicial practice, providing clarity and consistency across federal courts and ensuring the new penalties are effectively applied.

Case against: No significant case against this procedural directive, as it aims to implement the bill's core intent regarding penalties.

Estimated impact: Ensures the new penalties are effectively applied by courts, impacting future sentencing outcomes for relevant offenses by guiding judges in their decisions.

About this analysis. AI-Generated from the official bill text and available committee reports. Gaps in available data are noted explicitly. Verify important details with the official Congress.gov record.

On this page

  • Executive summary
  • Key provisions
  • Buried treasure
  • Follow the money
  • Critical analysis
  • Questions to ask
Ask Ledger AI about this